RE:Happy?fossi, "Is a single person here on the message board happy with Ceapro's development and Gilles' performance over the past weeks - months - years?"
In the markets there are boom or harvest years. There are bust or drought years. We've been in the worst biotech bear market or drought in history. It has been historic due to multi-decade high inflation and interest rates surging. This is a time for survival and to show resilience in biotech. That is the measureo of happiness. CZO has demonstrated its resilience with key pipeline projects now before important milestones, the cash to get there, and no debt. As many biotech companies are going bankrupt, undergoing reorganization, or experiencing massive dilution to bail them out CZO is positioned to look at other companies and see if it can build strength ahead of its key catalysts. CZO could be stronger than ever ahead of its key catalysts and as the boom years in biotech potentially approach once again.
Five year returns:
S&P Biotech ETF down 18.3%.
CZO down 5.95%.
CZO's base business has kept the company viable in this historic bear market for biotech. CZO has been resilient.